REVIEW 1 cited by
Scheduling Techniques for Liver Segmentation: ReduceLRonPlateau Vs OneCycleLR
Not yet reviewed by Pith; the record is open.
This paper has not been read by Pith yet. Machine review is queued; the pith claim, tier, and objections will appear here once it completes.
SPECIMEN: schema-true, not a live event
T0 review · schema-true
One-sentence machine reading of the paper's core claim.
pith:XXXXXXXX · record.json · timestamp
read the original abstract
Machine learning and computer vision techniques have influenced many fields including the biomedical one. The aim of this paper is to investigate the important concept of schedulers in manipulating the learning rate (LR), for the liver segmentation task, throughout the training process, focusing on the newly devised OneCycleLR against the ReduceLRonPlateau. A dataset, published in 2018 and produced by the Medical Segmentation Decathlon Challenge organizers, called Task 8 Hepatic Vessel (MSDC-T8) has been used for testing and validation. The reported results that have the same number of maximum epochs (75), and are the average of 5-fold cross-validation, indicate that ReduceLRonPlateau converges faster while maintaining a similar or even better loss score on the validation set when compared to OneCycleLR. The epoch at which the peak LR occurs perhaps should be made early for the OneCycleLR such that the super-convergence feature can be observed. Moreover, the overall results outperform the state-of-the-art results from the researchers who published the liver masks for this dataset. To conclude, both schedulers are suitable for medical segmentation challenges, especially the MSDC-T8 dataset, and can be used confidently in rapidly converging the validation loss with a minimal number of epochs.
Forward citations
Cited by 1 Pith paper
-
Structure-Aware Compound-Protein Affinity Prediction via Graph Neural Networks with Group Lasso Regularization
Adding common-plus-uncommon substructure masks and group lasso or sparse group lasso losses to activity-cliff GNNs improves per-target pIC50 prediction and attribution consistency on six tyrosine kinases.
Discussion (0). Continue with ORCID to comment.